Growing Need to Lower Disease Burden Expected To Promulgate Growth of Global Immunofluorescence Assay Market
Immunofluorescence assay is a method involved in antibody-antigen reactions. The antibody involved in assays is labeled with fluorescence dye and is permitted to intertwine with its available complementary antigen. The antibody-antigen complex is then visualized in a microscope, automated imaging instrument, flow cytometer, or array scanner. The approach is utilized for studying specific proteins in the culture, cell patient body fluid sample, and several others. There are two kinds of immunofluorescence assays namely, indirect and direct immunofluorescence. The assays need a reagent, instruments, antigen-specific antibodies, assay kits, and reagents.
The growing prevalence of chronic diseases all across the globe is one of the major factors driving the growth of the global immunofluorescence assay market. The government is taking several initiatives to lower the burden of diseases like cardiovascular disease, diabetes, infectious diseases, and neurological disorders over national health infrastructure. Moreover, the growing research and development activities to improve the quality of tests and protocols are also supporting the growth of the market globally. However, the emergence of a large number of hospitals and healthcare centers all across the globe will significantly boost the research activities for innovating drugs for rare ailments, thereby fueling the growth of the market globally.
The global immunofluorescence assay market can be segmented into end-user, type, product, and region.
By end-user, the market can be segmented into academic & research institutes, pharmaceutical and biotechnology companies, and others.
By type, the market can be segmented into direct and indirect immunofluorescence.
By product, the market can be segmented into instruments, kits, antibodies, and reagents.
North America accounts for the largest share in the global immunofluorescence assay market due to the growing incidences of cancer disease in the region. Moreover, the increasing investment for the development of innovative drugs will further promulgate the growth of the regional market.
Get Sample of this Research Report for more Insights – https://www.zionmarketresearch.com/sample/immunofluorescence-assay-market
Some of the significant players in the global immunofluorescence assay market are Maravai LifeSciences, Thermo Fisher Scientific, Inc., Abcam plc, Dickinson and Company, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Cell Signaling Technology, Inc., MEDIPAN GmbH, Sino Biological, Inc., Danaher Corporation, Enzo Biochem, Inc., Olympus Corporation, Nikon Corporation, Bruker Corporation, Agilent Technologies, Celebs, Zyagen, Inc., J. Mitra & Co. Pvt. Ltd., Abnova Corporation, EpiGentek Group, Elabscience, Inc., AESKU GROUP GmbH, Becton, and MaxVision Biosciences Inc. To cite, Merck KGaA in 2020 invested EUR 18 million to establish Life Sciences Laboratory in Switzerland to escalate research and development activities along with boosting the analytic production.
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us –
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651